Medical research

Drew Weissman, Nobel-winning mRNA pioneer

Drew Weissman's decades of research into mRNA technology paved the way for COVID-19 vaccines, finally earning a Nobel prize for the physician-scientist.

Immunology

Making immunotherapy safe for AML

Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...

Oncology & Cancer

New mechanism behind multiple myeloma cancer cell growth revealed

Researchers from Uppsala University have revealed one of the mechanisms behind the growth of cancer cells in the blood cancer multiple myeloma. The study shows that the protein EZH2 interacts with a specific RNA molecule ...

Immunology

Study identifies new pathway to suppressing autoimmunity

Researchers at Stanford University School of Medicine, Yale University School of Medicine, and the Hospital for Special Surgery Research Institute have uncovered new details about how the immune system prevents the production ...

Diseases, Conditions, Syndromes

A human protein found in non-immune cells defends against COVID-19

Earlier this month, health authorities confirmed that BA.2.86, a highly mutated variant of the virus that causes COVID-19, is at risk of spreading rapidly in countries around the world. With updated shots rolling out this ...

Oncology & Cancer

Closing in on a cure for common leukemia

A leukemia test can help identify patients who are strong candidates for lifelong treatment free remission (TFR)—meaning they are effectively cured of the disease.

page 7 from 40